Asian Science Citation Index is committed to provide an authoritative, trusted and significant information by the coverage of the most important and influential journals to meet the needs of the global scientific community.  
ASCI Database
308-Lasani Town,
Sargodha Road,
Faisalabad, Pakistan
Fax: +92-41-8815544
Contact Via Web
Suggest a Journal
Asian Journal of Biochemistry
Year: 2007  |  Volume: 2  |  Issue: 2  |  Page No.: 147 - 151

Administration of Antiretroviral Drugs(Lamivudine, Nevirapine and Stavudine) has no Untoward Effect on Haematological Profile in Albino Rats

R.A. Umar, M.J. Ladan, S.W. Hassan, Y. Sa`id, A.Y. Abbas and I.B. Oduolisaeme    

Abstract: The sub-Saharan African region is home to the greatest burden of Human Immunodeficiency Virus infection and Acquired Immunodeficiency Syndrome (HIV/AIDS). Appropriate management of infectious diseases is the most cost effective intervention to reduce the burden of disease. Highly Active Anti Retroviral Therapy (HAART) is the mainstay for inhibiting the multiplication of the causative agent and improving quality of life of the victims. There is some doubt in the region regarding the safety of the drugs in the anti AIDS pharmacy. Local studies on the safety of these agents are few. We studied the effects of acute and sub-acute oral administration of Lamivudine, Nevirapine and Stavudine on haematological profiles in albino rats. The rats were administered acute and sub-acute doses of Lamivudine, Nevirapine and Stavudine. Packed Cell Volume (PCV), total white blood cell count and differentials were determined by standard haematological methods. There were no significant differences (p<0.05) in the parametres except in PCV, eosinophils, neutrophils and leucocyte count associated with nevirapine and leucocytes and eosinophils associated with lamivudine. We conclude that acute and sub-acute oral administration of these drugs is associated with few haematological abnormalities and is therefore safe.

Cited References   |    Fulltext    |   Related Articles   |   Back
   
 
 
 
  Related Articles

 
 
 
 
 
 
 
 
 
Copyright   |   Desclaimer   |    Privacy Policy   |   Browsers   |   Accessibility